Clinical Trials Browser

Phase 1 × Interventional × Hepatitis B × Clear all

NCT02143401 2024-11-22

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

Gastrointestinal

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms

NCT04032392 2019-07-25

Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells

Phase 1 Unknown

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular